版本:
中国

BRIEF-Aldeyra Therapeutics expects to report results from phase 2A trial of topical ocular ADX-102 late in Q3

June 15 Aldeyra Therapeutics Inc:

* Aldeyra Therapeutics-expects to report results from phase 2a trial of topical ocular ADX-102 late in Q3, 2017, not early in Q3 as stated in conf call Source text: (bit.ly/2rBbbkk) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐